Skip to main content

Table 4 Final outcomes at the end of study

From: Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Outcome

ACEi/ARB n (%)

Available number

Non-ACEi/ARB n (%)

Available number

Died in hospital

258 (48)

538

109 (55)

199

Discharged alive from hospital

226 (42)

538

68 (34)

199

Transferred to another facility

7 (1)

538

1 (1)

199

Outcome not finalised

47 (9)

538

21 (11)

199

Recorded cause of death

 Cardiac Failure

16 (6)

258

4 (4)

109

 Cerebrovascular accident

3 (1)

258

3 (3)

109

 Haemorrhagic shock

3 (1)

258

0 (0)

109

 Multi-organ failure

85 (33)

258

29 (27)

109

 Respiratory failure

100 (39)

258

47 (43)

109

 Septic shock

14 (5)

258

15 (14)

109

 Other

19 (7)

258

7 (6)

109

 Missing

18 (7)

258

4 (4)

109

  1. Cause of death information is provided for patients known to have died in hospital
  2. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker